labocyte.varastegan@gmail.com
https://instagram.com/labocyte?utm_medium=copy_link
https://t.me/mlssa_varastegan
تهیه کنندگان: محمدرضا نادری، محمدجواد امینی، زهرا جوادی، نگار نشات، عارفه چراغچی، محمدرضا عبدی، تهمینه رحیمی
سردبیر: تهمینه رحیمی
:منابع
- https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html
- https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-(b.1.1.529)-technical-brief-and-priority-actions-for-member-states
- https://www.healthline.com/health-news/why-omicron-covid-19-cases-are-usually-less-severe-than-delta-cases
- https://www.webmd.com/vaccines/covid-19-vaccine/news/20220124/booster-shots-effective-preventing-omicron-hospitalizations-cdc
- https://www.medicalnewstoday.com/articles/pfizer-vaccine-for-coronavirus
- https://www.medicalnewstoday.com/articles/coronavirus-vaccine
- Saeed, U., Uppal, S. R., Piracha, Z. Z., & Uppal, R. (2021). SARS-CoV-2 Spike Antibody Levels Trend among Sinopharm Vaccinated People. Iranian journal of public health, 50(7), 1486–1487. https://doi.org/10.18502/ijph.v50i7.6640
- Jassat, Waasila and Karim, Salim Abdool and Mudara, Caroline and Welch, Richard and Ozougwu, Lovelyn and Groome, Michelle and Govender, Nevashan and von Gottberg, Anne and Wolter, Nicole and Group, DATCOV Author and Blumberg, Lucille and Cohen, Cheryl, Clinical Severity of COVID-19 Patients Admitted to Hospitals in Gauteng, South Africa During the Omicron-Dominant Fourth Wave (December 29, 2021)
- https://doi.org/10.1101/2022.01.27.22269909
- Thompson MG, Burgess JL, Naleway AL, Tyner HL, Yoon SK, Meece J, Olsho LE, Caban-Martinez AJ, Fowlkes A, Lutrick K, Kuntz JL. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers—eight US locations, December 2020–March 2021. Morbidity and Mortality Weekly Report. 2021 Apr 2;70(13):495
- Lyngse FP, Mortensen LH, Denwood MJ, Christiansen LE, Møller CH, Skov RL, Spiess K, Fomsgaard A, Lassauniere R, Rasmussen M, Stegger M. SARS-CoV-2 Omicron VOC Transmission in Danish Households. medRxiv. 2021 Jan 1
- Keeton R, Tincho MB, Ngomti A, Baguma R, Benede N, Suzuki A, Khan K, Cele S, Bernstein M, Karim F, Madzorera SV. SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron. MedRxiv. 2021 Jan 1.
- Gardner BJ, Kilpatrick AM. Estimates of reduced vaccine effectiveness against hospitalization, infection, transmission and symptomatic disease of a new SARS-CoV-2 variant, Omicron (B. 1.1. 529), using neutralizing antibody titers. MedRxiv. 2021 Jan 1.(
- Garcia-Beltran WF, Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell. 2022 Jan 6
- https://doi.org/10.1101/2021.12.02.470946
- Dyer, O., 2021. Covid-19: South Africa’s surge in cases deepens alarm over omicron variant.
- Karim, S.S.A. and Karim, Q.A., 2021. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. The Lancet.
